Table 2.
Comparison of admission laboratory data between deaths and survivors
| Deaths(n = 24)* | Survivors(n = 77)* | P | |
|---|---|---|---|
| NLR | 14.13 (7.67–23.04) | 5.93 (2.60–8.70) | 0.000 |
| PLR | 230.00 (102.25–396.24) | 157.29 (103.99–243.52) | 0.193 |
| MLR | 0.80 (0.44–1.27) | 0.44 (0.31–0.77) | 0.004 |
| WBC, × 109/L | 13.84 (8.80–17.47) | 9.74 (6.62–12.71) | 0.001 |
| Neutrophil, ×109/L | 12.21 (8.04–15.85) | 6.20 (3.98–9.91) | 0.000 |
| Lymphocyte, ×109/L | 0.82 (0.51–1.59) | 1.21 (0.90–1.82) | 0.017 |
| Monocyte, ×109/L | 0.63 (0.36–0.89) | 0.63 (0.45–0.99) | 0.621 |
| PLT, ×109/L | 163.50 (131.25–215.25) | 199.00 (141.00–247.00) | 0.273 |
| MPV, fL | 10.15 (9.30–10.78) | 10.10 (9.40–10.88) | 0.631 |
| PDW | 12.75 (11.28–15.80) | 13.25 (10.73–16.08) | 0.990 |
| Hb, g/L | 121.00 (108.25–141.50) | 108.00 (90.00–119.00) | 0.795 |
| RDW | 13.15 (12.73–15.33) | 13.20 (12.45–14.35) | 0.369 |
| Creatinine, μmol/L | 84.40 (71.72–106.50) | 72.00 (59.75–87.00) | 0.023 |
| GLU, mmol/L | 8.19 (6.95–13.83) | 7.60 (5.56–9.92) | 0.054 |
| Albumin, g/L | 32.33 (27.37–35.69) | 38.20 (32.49–45.80) | 0.008 |
*All variables are describe as median and interquartile range
NLR neutrophil-to-lymphocyte ratio, PLR platelet to lymphocyte ratio, WBC white blood cell, MLR monocyte-to-lymphocyte ratio, PLT platelet, MPV mean platelet volume, PDW platelet distribution width, Hb hemoglobin, RDW red cell distribution width, GLU glucose